Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      5 trials found for Urothelial, Bladder cancer

      All(5)
      Recruiting(5)
      Not yet recruiting(0)
      2 trials recruiting
      1 trial not yet recruiting
      Be6A Clinical Trials

      Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.

      Recruiting
      NCT04389632
      A Study of SGN-B6A in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      154study location(s)
      Recruiting
      NCT05902494
      HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

      Urothelial Carcinoma

      Male or Female
      18+ years
      19study location(s)
      Recruiting
      NCT05911295
      Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      101study location(s)
      Recruiting
      NCT04879329
      A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      79study location(s)
      Recruiting
      NCT05775471
      Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

      Renal Pelvis and Ureter Urothelial Carcinoma

      Male or Female
      18+ years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(5)
      Recruiting(5)
      Not yet recruiting(0)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.